Alexion Pharmaceuticals

SOLIRIS

Manufacturer:

Alexion Pharmaceuticals

Soliris HCPCS:

J1300

HCPCS Code Descriptor:

Injection, eculizumab, 10 mg

Category:

J Code

Soliris NDCs:

25682-0001-01

Primary Type:

Unclassified

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Soliris:

SOLIRIS is an Unclassified drug manufactured by Alexion Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J1300 is aligned to the drug SOLIRIS.

ACCESS PRICING AND MORE BY REGISTERING

J1300 Added Date:

January 1, 2008

J1300 Effective Date:

January 1, 2008

J1300 Termination Date:

HCPCS Active

Soliris billing and coding information can be found through Alexion Pharmaceuticals at the link below:
Soliris patient assistance information can be found through Alexion OneSource at the URL: https://alexiononesource.com/what-is-onesource/
SOLIRIS prescribing information can be found at the link below:
Information regarding SOLIRIS’s side effects can be found at MedlinePlus